Severe cutaneous toxicity following treatment with radiotherapy and cetuximab: A case report

Cases Journal

Volumn 2, Issue 1, 2009, Pages

  Azad, Arun ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; METOPROLOL; SULFADIAZINE; VALGANCICLOVIR;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; HEAD AND NECK CARCINOMA; HUMAN; MALE; RADIATION DERMATITIS; RASH; SINGLE DRUG DOSE; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA;

EID: 68049102263     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.1186/1757-1626-2-25     Document Type: Article

References (8)

1. Grandis JR, Tweardy DJ: Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993, 53(15):3579-3584.
2. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006, 354(6):567-578. (Pubitemid 43209104)
3. Budach W, Bolke E, Homey B: Severe cutaneous reaction during radiation therapy with concurrent cetuximab. N Engl J Med 2007, 357(5):514-515. (Pubitemid 47204904)
4. Berger B, Belka C: Severe skin reaction secondary to concomitant radiotherapy plus cetuximab. Radiat Oncol 2008, 3:5.
5. Mydin AR, Armstrong JG: Acneiform rash secondary to cetuximab plus head and neck radiotherapy. Radiother Oncol 2007, 85(1):171.
6. Jacot W, Bessis D, Jorda E, Ychou M, Fabbro M, Pujol JL, Guillot B: Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours. Br J Dermatol 2004, 151(1):238-241. (Pubitemid 39061311)
7. Busam KJ, Capodieci P, Motzer R, Kiehn T, Phelan D, Halpern AC: Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. Br J Dermatol 2001, 144(6):1169-1176. (Pubitemid 34204207)
8. Bernier J, Bonner J, Vermorken JB, Bensadoun RJ, Dummer R, Giralt J, Kornek G, Hartley A, Mesia R, Robert C, Segaert S, Ang KK: Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol 2008, 19(1):142-149.